BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18522708)

  • 1. Fatal hemolytic disease of the fetus and newborn associated with anti-Jr.
    Peyrard T; Pham BN; Arnaud L; Fleutiaux S; Brossard Y; Guerin B; Desmoulins I; Rouger P; Le Pennec PY
    Transfusion; 2008 Sep; 48(9):1906-11. PubMed ID: 18522708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic disease of the newborn associated with anti-Jra alloimmunization in a twin pregnancy: the first case report in Korea.
    Kim H; Park MJ; Sung TJ; Choi JS; Hyun J; Park KU; Han KS
    Korean J Lab Med; 2010 Oct; 30(5):511-5. PubMed ID: 20890084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: massive postpartum transfusion of Jr(a+) red cells in the presence of anti-Jra.
    Yuan S; Armour R; Reid A; Abdel-Rahman KF; Rumsey DM; Phillips M; Nester T
    Immunohematology; 2005; 21(3):97-101. PubMed ID: 16178666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic disease of the fetus and newborn caused by an antibody to a low-prevalence antigen, anti-SARA.
    Towns D; Hannon J; Hendry J; Barnes J; Goldman M
    Transfusion; 2011 Sep; 51(9):1977-9. PubMed ID: 21414007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal hemolytic disease of the fetus and newborn caused by anti-Jr
    Kim MS; Kim JS; Park H; Chung Y; Kim H; Ko DH; Hwang SH; Won HS; Oh HB
    Transfus Apher Sci; 2020 Feb; 59(1):102605. PubMed ID: 31324575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.
    Wikman A; Edner A; Gryfelt G; Jonsson B; Henter JI
    Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic disease of the newborn due to anti-Jra from a Chinese mother with one novel and one classic heterozygous mutation.
    Xiao J; Yang Q; Gao S; Song H; Zhao F; Guo Z; Zhang Y; Zhu Z; Ye L; Xiang D
    Transfus Med; 2023 Aug; 33(4):297-305. PubMed ID: 36971189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of extremely severe fetal anemia due to anti-Jra alloimmunization.
    Ishihara Y; Miyata S; Chiba Y; Kawai T
    Fetal Diagn Ther; 2006; 21(3):269-71. PubMed ID: 16601336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic disease of the fetus and newborn caused by anti-Lan.
    Brooks S; Squires JE
    Transfusion; 2014 May; 54(5):1317-20. PubMed ID: 24188628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Co(a) implicated in severe haemolytic disease of the foetus and newborn.
    Michalewska B; Wielgos M; Zupanska B; Bartkowiak R
    Transfus Med; 2008 Feb; 18(1):71-3. PubMed ID: 18179649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of anti-Jra: report of two cases and review of the literature.
    Kwon MY; Su L; Arndt PA; Garratty G; Blackall DP
    Transfusion; 2004 Feb; 44(2):197-201. PubMed ID: 14962310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody-dependent hemolysis and erythroid precursor cell growth inhibition.
    Blackall DP; Pesek GD; Montgomery MM; Oza KK; Arndt PA; Garratty G; Shahcheraghi A; Denomme GA
    Am J Perinatol; 2008 Oct; 25(9):541-5. PubMed ID: 18720327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jr
    Katsuragi S; Ohto H; Yoshida A; Otake A; Tsuneyama H; Ogasawara K; Isa K; Ikeda T
    Transfus Med Rev; 2019 Jul; 33(3):183-188. PubMed ID: 31227265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.